Identification and characterization of topoisomerase II inhibitory peptides from soy protein hydrolysates

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 15, 2008, Pages 6267-6277

  Wang, Wenyi ^a   Rupasinghe, Sanjeewa G ^b   Schuler, Mary A ^b   De Mejia, Elvira Gonzalez ^a,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NONE   (United States)

Author keywords

Dietary inhibitors; Molecular docking; Soy peptides; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME INHIBITOR; PANCREATIN; PEPSIN A; PEPTIDE; SOYBEAN PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; HYDROLYSIS; IMMUNOPRECIPITATION; METABOLISM;

AMINO ACID SEQUENCE; BINDING SITES; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; HUMANS; HYDROLYSIS; IMMUNOPRECIPITATION; MODELS, MOLECULAR; PANCREATIN; PEPSIN A; PEPTIDES; SOYBEAN PROTEINS;

GLYCINE MAX;

EID: 50449084334     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8005195     Document Type: Article

References (50)

1. Nielsen, N. C. Soybean seed composition. In Soybean: Genetics, Molecular Biology and Biotechnology; Verma, D. P. S., Shoemaker, R. C. Eds.; CAB International: Wallingford, U.K., 1996; pp 127-163.
2. Korhonen, H.; Pihlanto, A. Food-derived bioactive peptides-opportunities for designing future foods. Curr. Pharm. Des. 2003, 9, 1297-1308.
3. Wang, W.; de Mejia, E. G. A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Compr. Rev. Food Sci. Food Saf. 2005, 4, 63-78.
4. Hvalby, O.; Hemmings, H., Jr.; Paulsen, O.; Czernik, A.; Nairn, A.; Godfraind, J.; Jensen, V.; Raastad, M.; Storm, J.; Andersen, P.; Greengard, P. Specificity of protein kinase inhibitor peptides and induction of long-term potentiation. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4761-4765.
5. Klemm, M.; Cheng, C.; Cassell, G.; Shuman, S.; Segall, A. M. Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases. J. Mol. Biol. 2000, 299, 1203-1216.
6. Wang, J. C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 2002, 3, 430-440.
7. Cattan, A.; Levett, D.; Douglas, E.; Middleton, P.; Taylor, P. Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia. J. Clin. Pathol. 1996, 49, 848-852.
8. Potter, A. J.; Rabinovitch, P. S. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Mutat. Res. 2005, 572, 27-44.
9. Wang, B.; Perchellet, E. M.; Wang, Y.; Tamura, M.; Hua, D. H.; Perchellet, J. H. Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities. Anticancer Drugs 2003, 14, 503-514.
10. Marshall, K. M.; Holden, J. A.; Koller, A.; Kashman, Y.; Copp, B. R.; Barrows, L. R. AK37: the first pyridoacridine described capable of stabilizing the topoisomerase I cleavable complex. Anticancer Drugs 2004, 15, 907-913.
11. Mistry, P.; Stewart, A. J.; Dangerfield, W.; Baker, M.; Liddle, C.; Bootle, D.; Kofler, B.; Laurie, D.; Denny, W. A.; Baguley, B.; Charlton, P. A. In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and II. Anticancer Drugs 2002, 13, 15-28.
12. Christmann-Franck, S.; Bertrand, H.; Goupil-Lamy, A.; derGarabedian, P. A.; Mauffret, O.; Hoffmann, R.; Fermandjian, S. Structure-based virtual screening: an application to human topoisomerase II. J. Med. Chem. 2004, 47, 6840-6853.
13. Smiley, R. D.; Collins, T. R. L.; Hammes, G. G.; Hsieh, T. Single-molecule measurements of the opening and closing of the DNA gate by eukaryotic topoisomerase II. Proc. Natl. Acad Sci. U.S.A. 2007, 104, 4840-4845.
14. Davagnino, J.; Herrero, M.; Furlong, D.; Moreno, F.; Kolter, R. The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins 1986, 1, 230-238.
15. Vizan, J. L.; Hernandez-Chico, C.; del Castillo, I.; Moreno, F. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J. 1991, 10, 467-476.
16. Yoshinari, T.; Okada, H.; Yamada, A.; Uemura, D.; Oka, H.; Suda, H.; Okura, A. Inhibition of topoisomerase II by a novel antitumor cyclic depsipeptide, BE-22179. Jpn. J. Cancer Res. 1994, 85, 550-555.
17. Martin, L. M. Potent topoisomerase inhibition by synthetic cationic tetrapeptides constructed using unusual amino acids. Biopolymers 2003, 71, 398-398.
18. Gouda, K. G. M.; Gowda, L. R.; Rao, A. G. A.; Prakash, V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J. Agric. Food Chem. 2006, 54, 4568-4573.
19. Yang, Y.; Tao, G.; Liu, P.; Liu, J. Peptide with angiotensin I-converting enzyme inhibitory activity from hydrolyzed corn gluten meal. J. Agric. Food Chem. 2007, 55, 7891-7895.
20. Qian, Z.; Je, J.; Kim, S. Antihypertensive effect of angiotensin I converting enzyme-inhibitory peptide from hydrolysates of bigeye tuna dark muscle Thunnus obesus. J. Agric. Food Chem. 2007, 55, 8398-8403.
21. Megias, C.; Yust, M. M.; Pedroche, J.; Lquari, H.; Giron-Calle, J.; Alaiz, M.; Millan, F.; Vioque, J. Purification of an ACE inhibitory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates. J. Agric. Food Chem. 2004, 52, 1928-1932.
22. Adler-Nissen, J. Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J. Agric. Food Chem. 1979, 27, 1256-1262.
23. Gonzalez de Mejía, E.; Chandra, S.; Ramírez-Mares, M.; Wang, W. Catalytic inhibition of human DNA topoisomerase by phenolic compounds in Ardisia compressa extracts and their effect on human colon cancer cells. Food Chem. Toxicol. 2006, 44, 1191-1203.
24. Altschul, S. F.; Madden, T. L.; Schaffer, A. A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389-3402.
25. Classen, S.; Olland, S.; Berger, J. M. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 10629-10634.
26. MacKerell, A. D., Jr.; Bashford, D.; Bellott, M.; Dunbrack, R. L., Jr.; Evanseck, J. D.; Field, M. J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S.; Joseph-McCarthy, D.; Kuchnir, L.; Kuczera, K.; Lau, F. T. K.; Mattes, C.; Michnick, S.; Ngo, T.; Nguyen, D. T.; Prodhom, B.; Reiher, W. E., III; Roux, B.; Schlenkrich, M.; Smith, J. C.; Stote, R.; Straub, J.; Watanabe, M.; Wiórkiewicz-Kuczera, J.; Yin, D.; Karplus, M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 1998, 102, 3586-3616.
27. Halgren, T. A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
28. Baudry, J.; Li, W.; Pan, L.; Berenbaum, M. R.; Schuler, M. A. Molecular docking of substrates and inhibitors in the catalytic site of CYP6B1, an insect cytochrome P450 monooxygenase. Protein Eng. 2003, 16, 577-587.
29. Lo, W. M. Y.; Li-Chan, E. C. Y. Angiotensin I converting enzyme inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J. Agric. Food Chem. 2005, 53, 3369-3376.
30. Oyamada, Y.; Yamagishi, J.; Kihara, T.; Yoshida, H.; Wachi, M.; Ito, H. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor. Microbiol. Immunol. 2007, 51, 977-984.
31. Hernandez-Ledesma, B.; Davalos, A.; Bartolome, B.; Amigo, L. Preparation of antioxidant enzymatic hydrolysates from α-lactalbumin and β-lactoglobulin. Identification of active peptides by HPLC-MS/MS. J. Agric. Food Chem. 2005, 53, 588-593.
32. Geerlings, A.; Villar, I. C.; Zarco, F. H.; Sanchez, M.; Vera, R.; Gomez, A. Z.; Boza, J.; Duarte, J. Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk. J. Dairy Sci. 2006, 89, 3326-3335.
33. Gouda, K. G. M.; Gowda, L. R.; Rao, A. G. A.; Prakash, V. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max). J. Agric. Food Chem. 2006, 54, 4568-4573.
34. Megias, C.; Pedroche, J.; Yust, M. M.; Alaiz, M.; Giron-Calle, J.; Millan, F.; Vioque, J. Affinity purification of angiotensin converting enzyme inhibitory peptides using immobilized ACE. J. Agric. Food Chem. 2006, 54, 7120-7124.
35. Megias, C.; Pedroche, J.; Yust, M. M.; Alaiz, M.; Giron-Calle, J.; Millan, F.; Vioque, J. Immobilization of angiotensin-converting enzyme on glyoxyl-agarose. J. Agric. Food Chem. 2006, 54, 4641-4645.
36. Ni, J.; Chan, K. Sequence verification of oligonucleotides by electrospray quadrupole time-of flight mass spectrometry. Rapid Commun. Mass Spectrom. 2001, 15, 1600-1608.
37. Morris, H. R.; Paxton, T.; Panico, M.; McDowell, R.; Dell, A. A novel geometry mass spectrometer, the Q-TOF, for low-femtomol/attomole-range biopolymer sequencing. J. Protein Chem. 1997, 16, 469-479.
38. Kim, S. B.; Ki, K. S.; Khan, M. A.; Lee, W. S.; Lee, H. J.; Ahn, B. S.; Kim, H. S. Peptic and tryptic hydrolysis of native and heated whey protein to reduce its antigenicity. J. Dairy Sci. 2007, 90, 4043-4050.
39. Agudelo, R. A.; Gauthier, S. F.; Pouliot, Y.; Marin, J.; Savoie, L. Kinetics of peptide fraction release during in vitro digestion of casein. J. Sci. Food Agric. 2004, 84, 325-332.
40. Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O'Donovan, C.; Phan, I. The SWISS-PROT protein knowledge-base and its supplement TrEMBL. Nucleic Acids Res. 2003, 31, 365-370.
41. Liu, K. S. Agronomic characteristics, production, and marketing. In Soybeans: Chemistry, Technology and Utilization; Chapman and Hall: New York, 1997; pp 1-24.
42. Wigley, D. B.; Davies, G. J.; Dodson, E. J.; Maxwell, A.; Dodson, G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature 1991, 351, 624-629.
43. Berger, J. M.; Gamblin, S. J.; Harrison, S. C.; Wang, J. C. Structure and mechanism of DNA topoisomerase II. Nature 1996, 379, 225-232.
44. Morais Cabral, J. H.; Jackson, A. P.; Smith, C. V.; Shikotra, N.; Maxwell, A.; Liddington, R. C. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997, 388, 903-906.
45. Brino, L.; Urzhumtsev, A.; Mousli, M.; Bronner, C.; Mitschier, A.; Oudet, P.; Moras, D. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J. Biol. Chem. 2000, 275, 9468-9475.
46. Fass, D.; Bogden, C. E.; Berger, J. M. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands. Nat. Struct. Biol. 1999, 6, 322-326.
47. Wei, H.; Ruthenburg, A. J.; Bechis, S. K.; Verdine, G. L. Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. J. Biol. Chem. 2005, 280, 37041-37047.
48. Schoeffler, A. J.; Berger, J. M. Recent advances in understanding structure-function relationships in the type II topoisomerase mechanism. Biochem. Soc. Trans. 2005, 33, 1465-1470.
49. Dal Ben, D.; Palumbo, M.; Zagotto, G.; Capranico, G.; Moro, S. DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation. Curr. Pharm. Des. 2007, 13, 2766-2780.
50. Das, B. B.; Sen, N.; Dasgupta, S. B.; Ganguly, A.; Das, R.; Majumder, H. K. Topoisomerase research of kinetoplastid parasite Leishmania, with special reference to development of therapeutics. Indian J. Med. Res. 2006, 123, 221-232.